During the past decade, Breakthrough Clinical Trials conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 6 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Breakthrough Clinical Trials" #1 sponsor was "Shire" with 2 trials, followed by "Corcept Therapeutics" with 1 trials sponsored, "Dr. Reddy's Laboratories Limited" with 1 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored and "Member Companies of the Opioid PMR Consortium" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

According to Clinical.Site data, the most researched conditions in "Breakthrough Clinical Trials" are "Major Depressive Disorder" (2 trials), "Acute Migraine" (1 trials), "Alzheimer Disease" (1 trials), "Clostridium Difficile Infection" (1 trials) and "Drug Abuse" (1 trials). Many other conditions were trialed in "Breakthrough Clinical Trials" in a lesser frequency.

Most popular intervention types in "Breakthrough Clinical Trials" are "Drug" (6 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Antidepressant + Placebo" (1 trials), "Antidepressant + SPD489 (Lisdexamfetamine dimesylate )" (1 trials), "Clostridium difficile vaccine" (1 trials), "Continuation of opioid therapy (morphine sulfate ER, oxycodone ER, oxymorphone ER)" (1 trials) and "DFN-02" (1 trials). Other intervention names were less common.

The vast majority of trials in "Breakthrough Clinical Trials" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Breakthrough Clinical Trials". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Breakthrough Clinical Trials, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Breakthrough Clinical Trials, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".